- Wednesday, March 29, 2023
7:00 AM – 8:00 AM
CE Symposia: Enhancing the Safety of Outpatient CAR T-Cell Administration in Relapsed/Refractory Lymphomas Through Pharmacist-Directed Initiatives
7:00 AM – 8:00 AM
CE Symposia: Enhancing the Safety of Outpatient CAR T-Cell Administration in Relapsed/Refractory Lymphomas Through Pharmacist-Directed InitiativesLocation: 159*Speaker: – The Hospital of the University of Pennsylvania
*Speaker:
*Speaker: – University of California, Irvine
Craig Freyer, PharmD, BCOP – The Hospital of the University of Pennsylvania ### 894758###*Speaker###Clinical Pharmacy Specialist in Hematology/Oncology, Allogeneic Stem Cell Transplant, and Cellular Therapy###The Hospital of the University of Pennsylvania###*Speaker: – The Hospital of the University of Pennsylvania
### @@@ Katie Gatwood, PharmD, BCOP ### 1545829###*Speaker#########*Speaker:
### @@@ Shawn P. Griffin, PharmD, BCOP (he/him/his) – University of California, Irvine ### 1772980###*Speaker###Assistant Clinical Professor###University of California, Irvine###*Speaker: – University of California, Irvine
### he/him/his7:00 AM – 8:00 AM
CE Symposia: Treatment Strategies for Chronic Myeloid Leukemia and the Pharmacist’s Impactful Role
7:00 AM – 8:00 AM
CE Symposia: Treatment Strategies for Chronic Myeloid Leukemia and the Pharmacist’s Impactful RoleLocation: 158*Speaker:
*Speaker: – University of North Carolina Eshelman School of Pharmacy
*Speaker: – UC San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences
Mimi Lo, PharmD, BCPS, BCOP ### 1894946###*Speaker#########*Speaker:
### @@@ Benyam Muluneh, PharmD, BCOP, CPP – University of North Carolina Eshelman School of Pharmacy ### 1137104###*Speaker###Clinical-Assistant Professor###University of North Carolina Eshelman School of Pharmacy###*Speaker: – University of North Carolina Eshelman School of Pharmacy
### @@@ Ila Saunders, PharmD, BCOP – UC San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences ### 900571###*Speaker###Assistant Clinical Professor###UC San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences###*Speaker: – UC San Diego Skaggs School of Pharmacy & Pharmaceutical Sciences
### 8:00 AM – 12:00 PM
Pre-Conference: Precision Medicine in Oncology
8:00 AM – 12:00 PM
001 - Pre-Conference: Precision Medicine in OncologyLocation: 150-151Speaker: – UNC Health
Co-Speaker: – Mayo Clinic
Co-Speaker: – Department of Veterans Affairs
Pre-Conference (Special Fee)
Amber B. Cipriani, PharmD, BCOP – UNC Health ### 1609190###Speaker###Precision Medicine Pharmacy Coordinator###UNC Health###Speaker: – UNC Health
### @@@ Sara Maloney, PharmD, BCOP, MHSA (she/her/hers) – Mayo Clinic ### 1820763###Co-Speaker###Precision Oncology and Research Support Pharmacist###Mayo Clinic###Co-Speaker: – Mayo Clinic
### she/her/hers @@@ Jill Bates, PharmD, MS, BCOP, FASHP – Department of Veterans Affairs ### 1820764###Co-Speaker###Acting Deputy Executive Director National Pharmacogenomics Program###Department of Veterans Affairs###Co-Speaker: – Department of Veterans Affairs
###
12:00 PM – 1:00 PM
Non-CE Symposia: Advances in CLL Therapy: Practical Management of a BCL2-Inhibitor
12:00 PM – 1:00 PM
Non-CE Symposia: Advances in CLL Therapy: Practical Management of a BCL2-InhibitorLocation: 157*Speaker: – Boston Medical Center
Jasmine Patel, PharmD, BCOP – Boston Medical Center ### 947640###*Speaker###Clinical Pharmacy Specialist###Boston Medical Center###*Speaker: – Boston Medical Center
### 12:00 PM – 1:00 PM
Non-CE Symposia: How Is the Treatment of Patients With KRAS G12C-Mutated Advanced NSCLC Evolving?
12:00 PM – 1:00 PM
Non-CE Symposia: How Is the Treatment of Patients With KRAS G12C-Mutated Advanced NSCLC Evolving?Location: 159
Sandra Cuellar, PharmD BCOP ### 957901###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
Non-CE Symposia: Myelofibrosis and Strategies for Disease Management: Key Considerations for Patient Care
12:00 PM – 1:00 PM
Non-CE Symposia: Myelofibrosis and Strategies for Disease Management: Key Considerations for Patient Care Location: 158*Speaker: – The Hospital of the University of Pennsylvania
Craig Freyer, PharmD, BCOP – The Hospital of the University of Pennsylvania ### 894758###*Speaker###Clinical Pharmacy Specialist in Hematology/Oncology, Allogeneic Stem Cell Transplant, and Cellular Therapy###The Hospital of the University of Pennsylvania###*Speaker: – The Hospital of the University of Pennsylvania
### 12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
Location: Ballroom Lobby
1:15 PM – 2:15 PM
Early-Stage Breast Cancer – Updates in Management
1:15 PM – 2:15 PM
BC1 - Updates in Early-Stage Breast Cancer Location: BallroomSpeaker: – West Virginia University Medicine
BCOP
Jordan Hill, PharmD, BCOP – West Virginia University Medicine ### 1772979###Speaker###Clinical Pharmacy Specialist - Oncology###West Virginia University Medicine###Speaker: – West Virginia University Medicine
###
1:15 PM – 2:15 PM
Updates in the Management of Follicular and Mantle Cell Lymphomas
1:15 PM – 2:15 PM
101 - Updates in the Management of Follicular and Mantle Cell Lymphomas Location: 160-163Speaker: – UT MD Anderson Cancer Center
Brian Primeaux, PharmD, BCOP (he/him/his) – UT MD Anderson Cancer Center ### 1774213###Speaker###Clinical Pharmacy Specialist###UT MD Anderson Cancer Center###Speaker: – UT MD Anderson Cancer Center
### he/him/his
2:00 PM – 3:00 PM
President’s Welcome and Recognition of 2023 HOPA Fellows
2:30 PM – 3:00 PM
President’s Welcome and Recognition of 2023 HOPA FellowsLocation: Ballroom
Heidi D. Finnes, PharmD, BCOP, FHOPA – Mayo Clinic ### 1181746###Presenter###Senior Manager Pharmacy Cancer Research###Mayo Clinic###Presenter: – Mayo Clinic
### 3:15 PM – 4:15 PM
Platform Research: Bruton Tyrosine Kinase (BTK) Inhibitors: Real World Clinical Outcomes in a Diverse Patient Population at a Large Safety Net Hospital
3:15 PM – 3:30 PM
102 - Bruton Tyrosine Kinase (BTK) Inhibitors: Real World Clinical Outcomes in a Diverse Patient Population at a Large Safety Net HospitalLocation: BallroomCo-Speaker: – Boston Medical Center
Co-Speaker: – Boston Medical Center; Boston University School of Medicine
Research
Lynnette Henshaw, PharmD, BCOP – Boston Medical Center ### 1252186###Co-Speaker###Clinical Pharmacy Specialist-Hematology/Oncology###Boston Medical Center###Co-Speaker: – Boston Medical Center
### @@@ Camille Edwards, MBBS (she/her/hers) – Boston Medical Center; Boston University School of Medicine ### 1835778###Co-Speaker###Clinical Hematologist, Assistant Professor###Boston Medical Center; Boston University School of Medicine###Co-Speaker: – Boston Medical Center; Boston University School of Medicine
### she/her/hers
3:15 PM – 4:15 PM
Platform Research: Clinical Pharmacist-Initiated Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid Leukemia
3:30 PM – 3:45 PM
102 - Clinical Pharmacist-Initiated Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid LeukemiaLocation: BallroomPresenter: – Kaiser Permanente-Colorado
Research
Jared Freml, PharmD, BCOP – Kaiser Permanente-Colorado ### 1835776###Presenter###Clinical Pharmacy Specialist-Oncology###Kaiser Permanente-Colorado###Presenter: – Kaiser Permanente-Colorado
###
3:15 PM – 4:15 PM
Platform Research: Knowledge Gaps and Educational Needs for Common Cancer Therapy-Related Cardiovascular Toxicities and Related Drug Interactions
3:45 PM – 4:00 PM
102 - Knowledge Gaps for Cancer Therapy-Related Cardiovascular ToxicitiesLocation: BallroomCo-Speaker: – Duke University Medical Center
Research
Kristen T. Peterson, PharmD, BCOP – Duke University Medical Center ### 1835777###Co-Speaker###Clinical Oncology Pharmacist###Duke University Medical Center###Co-Speaker: – Duke University Medical Center
###
3:15 PM – 4:15 PM
Platform Research: Optimizing Corticosteroid Utilization for Immune-related Adverse Events at a Community Oncology Practice
4:00 PM – 4:15 PM
102 - Optimizing Corticosteroid Utilization for Immune-related Adverse Events at a Community Oncology PracticeLocation: BallroomPresenter: – Cancer & Hematology Centers of Western Michigan
Research
Christin M. Molnar, PharmD, BCOP (she/her/hers) – Cancer & Hematology Centers of Western Michigan ### 1511234###Presenter###Research Pharmacy Manager###Cancer & Hematology Centers of Western Michigan###Presenter: – Cancer & Hematology Centers of Western Michigan
### she/her/hers
4:30 PM – 5:30 PM
Significant Updates in Oncology
4:30 PM – 5:30 PM
103 - Significant Updates in OncologyLocation: 160-163Speaker: – ETSU Bill Gatton College of Pharmacy
John Bossaer, PharmD, BCOP (he/him/his) – ETSU Bill Gatton College of Pharmacy ### 1171474###Speaker###Professor###ETSU Bill Gatton College of Pharmacy###Speaker: – ETSU Bill Gatton College of Pharmacy
### he/him/his
4:30 PM – 5:30 PM
Updates in Hepatocellular Carcinoma
4:30 PM – 5:30 PM
BC2 - Updates in Hepatocellular CarcinomaLocation: BallroomSpeaker: – Vanderbilt University Medical Center
BCOP
Sarah K. Cimino, PharmD, BCPS, BCOP – Vanderbilt University Medical Center ### 1774205###Speaker###Clinical Pharmacist Specialist, Gastrointestinal Oncology###Vanderbilt University Medical Center###Speaker: – Vanderbilt University Medical Center
###
5:30 PM – 6:30 PM
Committee Networking Reception
5:30 PM – 6:30 PM
Committee Networking Reception
Location: Networking Lounge
5:30 PM – 7:30 PM
Welcome Reception
5:30 PM – 7:30 PM
Welcome Reception
Location: Exhibit Hall
5:45 PM – 6:30 PM
2023 Annual Advocacy Update (Non-CE)
5:45 PM – 6:30 PM
2023 Annual Advocacy Update (Non-CE)Location: BallroomCo-Speaker: – HOPA
Co-Speaker: – The Ohio State University Wexner Medical Center
Co-Speaker: – CRD Associates
Co-Speaker: – The University of Kansas Health System
Advocacy
Brooke Boring, MPH, CPhT (she/her/hers) – HOPA ### 1518390###Co-Speaker###Senior Manager of Health Policy & Advocacy###HOPA###Co-Speaker: – HOPA
### she/her/hers @@@ Jeff Pilz, PharmD, MPA, MS, BCPS – The Ohio State University Wexner Medical Center ### 1518389###Co-Speaker###Assistant Director of Pharmacy - Medication Safety and Drug Policy###The Ohio State University Wexner Medical Center###Co-Speaker: – The Ohio State University Wexner Medical Center
### @@@ Jeremy Scott, MA – CRD Associates ### 969263###Co-Speaker###Senior Vice President###CRD Associates###Co-Speaker: – CRD Associates
### @@@ Taylor Monson, PharmD, BCOP, BCPS (she/her/hers) – The University of Kansas Health System ### 1837553###Co-Speaker###Clinical Oncology Pharmacist###The University of Kansas Health System###Co-Speaker: – The University of Kansas Health System
### she/her/hers
6:30 PM – 7:15 PM
Non-CE Symposia: Evolving CLL Treatment Paradigms Exploring Chemo Free Regimens With A Fixed Treatment Duration
6:30 PM – 7:15 PM
Non-CE Symposia: Evolving CLL Treatment Paradigms Exploring Chemo Free Regimens With A Fixed Treatment DurationLocation: 159
Vincent Herrin, MD ### 1895967###*Speaker#########*Speaker:
### 6:30 PM – 7:15 PM
Non-CE Symposia: Treatment Options for Patients with Unresectable or Metastatic Melanoma
6:30 PM – 7:15 PM
Non-CE Symposia: Treatment Options for Patients with Unresectable or Metastatic MelanomaLocation: 158
Kevin McWilliams, PharmD ### 1917214###*Speaker#########*Speaker:
### 6:30 PM – 7:30 PM
LGBTQ+ Reception
6:30 PM – 7:30 PM
LGBTQ+ Reception
Location: 150-151
- Thursday, March 30, 2023
7:00 AM – 8:00 AM
Exhibits and IRC Encore Posters
7:00 AM – 8:00 AM
Exhibits and IRC Encore Posters
Location: Exhibit Hall
7:00 AM – 8:00 AM
Non-CE Symposia: Advances in AML Therapy: Practical Management of a BCL2-Inhibitor
7:00 AM – 8:00 AM
Non-CE Symposia: Advances in AML Therapy: Practical Management of a BCL2-InhibitorLocation: 158
Ryan Beechinor, PharmD, BCSP, BCOP ### 1896093###*Speaker#########*Speaker:
### 7:00 AM – 8:00 AM
Non-CE Symposia: Title TBD (AstraZeneca)
7:00 AM – 8:00 AM
Non-CE Symposia: Use of a Targeted Agent For Previously Untreated or R/R CLLLocation: 159
Mark Wagner, PharmD ### 1917234###*Speaker#########*Speaker:
### 8:00 AM – 9:00 AM
Considerations in Opioid Tapering in Cancer Survivors
8:00 AM – 9:00 AM
201 - Considerations in Opioid Tapering in Cancer SurvivorsLocation: 164-167Speaker: – Vanderbilt University Medical Center
Taylor W. Butler, PharmD, BCOP, BCPS (he/him/his) – Vanderbilt University Medical Center ### 1774206###Speaker###Clinical Pharmacy Specialist - Cancer Pain###Vanderbilt University Medical Center###Speaker: – Vanderbilt University Medical Center
### he/him/his
8:00 AM – 9:00 AM
Current Approaches to Manage Mixed Phenotype Acute Leukemia (MPAL): A Recent Patient Case Analysis
8:00 AM – 9:00 AM
202 - Current Approaches in the Management of Mixed Phenotype Acute Leukemia (MPAL)Location: 160-163Speaker: – Brigham and Women's Hospital, Harvard Medical School
Jian Ni, Pharm.D., MPH, BCOP – Brigham and Women's Hospital, Harvard Medical School ### 1774208###Speaker###Oncology Pharmacy Clinical Specialist###Brigham and Women's Hospital, Harvard Medical School ###Speaker: – Brigham and Women's Hospital, Harvard Medical School
###
8:00 AM – 9:00 AM
From Blame & Shame We Overcame: Establishing a Multidisciplinary Cancer Medication Safety Committee
8:00 AM – 9:00 AM
203 - From Blame & Shame We Overcame: Establishing a Multidisciplinary Oncology Medication Safety CommitteeLocation: BallroomSpeaker: – University of Kansas Health System
Practice Management
Grace A. Martin, PharmD, BCOP – University of Kansas Health System ### 1774210###Speaker###Pharmacy Clinical Coordinator - Cancer Care###University of Kansas Health System###Speaker: – University of Kansas Health System
###
8:00 AM – 9:00 AM
Impact of Payor Driven Treatment Site of Care Initiatives: Balancing Safety, Quality and Cost
8:00 AM – 9:00 AM
203 - Treatment Site of Care Initiatives: Balancing Safety, Quality and CostLocation: BallroomPractice Management
Prabha Vogel, PharmD, BCOP, BCPS – Self Employed ### 1774209###Speaker###Consultant###Self Employed###Speaker: – Self Employed
###
8:00 AM – 9:00 AM
Polatuzumab-vedotin in upfront diffuse large b-cell lymphoma: efficacy versus financial toxicity
8:00 AM – 9:00 AM
202 - Polatuzumab-vedotin in Upfront Treatment of DLBCL: Overview of POLARIX Trial and Financial ConsiderationsLocation: 160-163Speaker: – Memorial Sloan Kettering Cancer Center
Andrea LeVoir, BCOP – Memorial Sloan Kettering Cancer Center ### 1171482###Speaker###Clinical Pharmacy Specialist###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
###
8:00 AM – 9:00 AM
What’s the risk? Update on the safe use of medicines in G6PD deficiency
8:00 AM – 9:00 AM
201 - What’s the Risk? Update on the Safe Use of Medicines in G6PD DeficiencyLocation: 164-167Speaker: – St. Jude Children's Research Hospital
Cyrine E. Haidar, PharmD, BCPS, BCOP, FASHP – St. Jude Children's Research Hospital ### 1772978###Speaker###Clinical Pharmacogenomics Senior Program Manager###St. Jude Children's Research Hospital###Speaker: – St. Jude Children's Research Hospital
###
9:15 AM – 10:30 AM
HOPA-ASCO Quality Training Program (QTP) 6-month Program Participants: Panel Discussion
9:15 AM – 10:30 AM
204 - HOPA-ASCO Quality Training Program (QTP) 6-month Program Participants Panel DiscussionLocation: BallroomLead Presenter: – Pharmacy Times Continuing Education
Lead Presenter: – University of Michigan Rogel Cancer Center
Practice Management
Amy L. Morris, PharmD – Pharmacy Times Continuing Education ### 1504251###Lead Presenter###Scientific Director, Oncology###Pharmacy Times Continuing Education###Lead Presenter: – Pharmacy Times Continuing Education
### @@@ Victoria R. Nachar, PharmD, BCOP – University of Michigan Rogel Cancer Center ### 1094223###Lead Presenter###Clinical Pharmacist###University of Michigan Rogel Cancer Center###Lead Presenter: – University of Michigan Rogel Cancer Center
###
10:45 AM – 12:00 PM
Controversies in Precision Oncology: Interpreting the Grey Areas
10:45 AM – 12:00 PM
205 - Controversies in Precision Oncology: Interpreting the Grey AreasLocation: 160-163Co-Speaker: – William S. Middleton Memorial Veterans Hospital
Co-Speaker: – Veterans Health Administration
Co-Speaker: – Moffitt Cancer Center
Jennie Piccolo, PharmD, BCOP (she/her/hers) – William S. Middleton Memorial Veterans Hospital ### 1774214###Co-Speaker###Clinical Hematology/Oncology Pharmacist Practitioner; National Precision Oncology Program Consultant###William S. Middleton Memorial Veterans Hospital###Co-Speaker: – William S. Middleton Memorial Veterans Hospital
### she/her/hers @@@ Ni-Chi Wu, PharmD, BCOP, BCPS – Veterans Health Administration ### 1518441###Co-Speaker###National TeleOncology Clinical Pharmacy Practitioner/National Precision Oncology Program Consultant###Veterans Health Administration###Co-Speaker: – Veterans Health Administration
### @@@ Christine M. Walko, PharmD, BCOP, FCCP (she/her/hers) – Moffitt Cancer Center ### 1390144###Co-Speaker###Associate Member, Department of Individualized Cancer Management, Precision Medicine Program Lead and Precision Medicine Clinical Service Attending###Moffitt Cancer Center###Co-Speaker: – Moffitt Cancer Center
### she/her/hers
10:45 AM – 12:00 PM
Evolving Landscape of Early Non-Small Cell Lung Cancer
10:45 AM – 12:00 PM
BC3 - The Constant Gardener: The Evolving Landscape of Early Non-Small Cell Lung CancerLocation: BallroomSpeaker: – University of Texas MD Anderson Cancer Center
BCOP
Whitney E. Lewis, PharmD, BCOP – University of Texas MD Anderson Cancer Center ### 1491265###Speaker###clinical pharmacy specialist###University of Texas MD Anderson Cancer Center###Speaker: – University of Texas MD Anderson Cancer Center
###
12:00 PM – 1:00 PM
Non-CE Symposia: Janssen Oncology invites you to learn more about a new treatment option for patients diagnosed with multiple myeloma who are relapsed/refractory and have received >=4 prior lines of therapy.
12:00 PM – 1:00 PM
Non-CE Symposia: Janssen Oncology invites you to learn more about a new treatment option for patients diagnosed with multiple myeloma who are relapsed/refractory and have received >=4 prior lines of therapy.Location: 157*Speaker: – M Health Fairview and Mayo Clinic College of Medicine
Kirollos Hanna, BCOP, BCPS, PharmD – M Health Fairview and Mayo Clinic College of Medicine ### 894762###*Speaker###Director of Pharmacy###M Health Fairview and Mayo Clinic College of Medicine###*Speaker: – M Health Fairview and Mayo Clinic College of Medicine
### 12:00 PM – 1:00 PM
Non-CE Symposia: A Treatment Option for Patients with Gastroesophageal Cancers
12:00 PM – 1:00 PM
Non-CE Symposia: A Treatment Option for Patients with Gastroesophageal CancersLocation: 159
Jeryl Villadolid ### 1922354###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
Non-CE Symposia: Discussion of BRUKINSA for adult patients with CLL/SLL
12:00 PM – 1:00 PM
Non-CE Symposia: Discussion of BRUKINSA for adult patients with CLL/SLL Location: 158
Justin D. Andras, PharmD, BCOP ### 1920043###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
Preparing for a Career in Hematology/Oncology Pharmacy Practice (Non-CE)
12:00 PM – 1:00 PM
Preparing for a Career in Hematology/Oncology Pharmacy Practice (Non-CE)Location: 160-163Speaker:
Speaker: – Atrium Health Wake Forest Baptist (WFB)
Speaker: – St. John's University
Speaker: – University of Kansas Cancer Center
Speaker: – MD Anderson Cancer Center
Sally Barbour, PharmD, BCOP, FHOPA ### 1917281###Speaker#########Speaker:
### @@@ LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA – Atrium Health Wake Forest Baptist (WFB) ### 1311883###Speaker###Clinical Specialist - Stem Cell Transplant and Cellular Therapy###Atrium Health Wake Forest Baptist (WFB)###Speaker: – Atrium Health Wake Forest Baptist (WFB)
### @@@ Chung-Shien Lee, PharmD, BCPS, BCOP – St. John's University ### 894784###Speaker###Assistant Professor###St. John's University###Speaker: – St. John's University
### @@@ Zahra Mahmoudjafari, PharmD, MBA, BCOP (she/her/hers) – University of Kansas Cancer Center ### 958456###Speaker###Clinical Pharmacy Manager-Hem/BMT/CAR-T###University of Kansas Cancer Center###Speaker: – University of Kansas Cancer Center
### she/her/hers @@@ Jason Yeh, PharmD, BCOP – MD Anderson Cancer Center ### 1518443###Speaker###Clinical Pharmacy Specialist / PGY2 Oncology Pharmacy RPD###MD Anderson Cancer Center###Speaker: – MD Anderson Cancer Center
### 12:00 PM – 1:00 PM
Quality Improvement
12:00 PM – 1:00 PM
Navigating the Sea of Quality Improvement: Charting Course Toward Successful Residency Projects. A Panel Discussion (non-CE)Location: 164-167Lead Facilitator: – University of Virginia Health
Co-Speaker: – University of Virginia Health
Co-Speaker: – Dana-Farber Cancer Institute
Co-Speaker: – Dana Farber Cancer Institute
Kathlene DeGregory, PharmD, BCOP (she/her/hers) – University of Virginia Health ### 1188659###Lead Facilitator###Clinical Pharmacist Stem Cell Transplant###University of Virginia Health###Lead Facilitator: – University of Virginia Health
### she/her/hers @@@ Hiba Alzouby, PharmD – University of Virginia Health ### 1913944###Co-Speaker###PGY2 Oncology Pharmacy Resident###University of Virginia Health###Co-Speaker: – University of Virginia Health
### @@@ Gayle C. Blouin, BCOP,PharmD,RPh (she/her/hers) – Dana-Farber Cancer Institute ### 958461###Co-Speaker###Clinical Pharmacy Manager###Dana-Farber Cancer Institute###Co-Speaker: – Dana-Farber Cancer Institute
### she/her/hers @@@ Yun Man, PharmD, BCOP (she/her/hers) – Dana Farber Cancer Institute ### 1552964###Co-Speaker###Medication Use Quality and Policy Specialist###Dana Farber Cancer Institute###Co-Speaker: – Dana Farber Cancer Institute
### she/her/hers
12:00 PM – 1:00 PM
Special Interest Group (SIG) Networking Luncheon
12:00 PM – 1:00 PM
Special Interest Group (SIG) Networking Luncheon
Location: Networking Lounge
12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
Location: Ballroom Lobby
12:00 PM – 2:00 PM
Poster Session - Trainee Research (Odd #)
12:00 PM – 2:00 PM
Poster Session - Trainee Research (Odd #)Location: Exhibit HallResearch
2:15 PM – 3:15 PM
John G. Kuhn Keynote Address: I’m Not Limping. That’s Swagger! (Non-CE)
2:15 PM – 3:15 PM
John G. Kuhn Keynote Address: I’m Not Limping. That’s Swagger! (Non-CE)Location: BallroomKeynote Speaker: – Kelsey Tainsh LLC
Kelsey Tainsh, Bachelor of Science in Recreation, Patient Advocate and Two time pediatric brain tumor and stroke survivor (she/her/hers) – Kelsey Tainsh LLC ### 1774212###Keynote Speaker###Professional Speaker###Kelsey Tainsh LLC###Keynote Speaker: – Kelsey Tainsh LLC
### she/her/hers3:30 PM – 4:45 PM
Optimizing Decision-Making for Treatment in Metastatic Renal Cell Carcinoma (mRCC): Balancing Evidence and Care Issues
3:30 PM – 4:45 PM
206 - Optimizing Decision-Making for Treatment of Metastatic Renal Cell Carcinoma (mRCC): Balancing Evidence and Care IssuesLocation: 160-163Speaker: – UConn School of Pharmacy
Co-Speaker: – University of Cincinnati James L. Winkle College of Pharmacy
Lisa M. Holle, PharmD, BCOP, FHOPA, FISOPP – UConn School of Pharmacy ### 1410920###Speaker###Clinical Professor###UConn School of Pharmacy###Speaker: – UConn School of Pharmacy
### @@@ Rowena N. Schwartz, PharmD, BCOP, FHOPA (she/her/hers) – University of Cincinnati James L. Winkle College of Pharmacy ### 894806###Co-Speaker###Professor of Pharmacy Practice###University of Cincinnati James L. Winkle College of Pharmacy###Co-Speaker: – University of Cincinnati James L. Winkle College of Pharmacy
### she/her/hers
3:30 PM – 4:45 PM
The Great Debate: Graft Versus Host Disease (GVHD) Prophylaxis Strategies (Encore)
3:30 PM – 4:45 PM
BC4 - The Great Debate: Graft Versus Host Disease (GVHD) Prophylaxis Strategies (Encore)Location: BallroomCo-Speaker: – Emory Healthcare - Winship Cancer Institute
Co-Speaker: – Mayo Clinic
Co-Speaker: – Moffitt Cancer Center
BCOP
Arpita Gandhi, PharmD, BCOP – Emory Healthcare - Winship Cancer Institute ### 1774202###Co-Speaker###Hematology/Oncology Clinical Pharmacy Specialist###Emory Healthcare - Winship Cancer Institute###Co-Speaker: – Emory Healthcare - Winship Cancer Institute
### @@@ Alexis K. Kuhn, PharmD, BCOP (she/her/hers) – Mayo Clinic ### 894768###Co-Speaker###Pediatric Oncology Pharmacist- Ambulatory Services###Mayo Clinic###Co-Speaker: – Mayo Clinic
### she/her/hers @@@ Rebecca Gonzalez, PharmD (she/her/hers) – Moffitt Cancer Center ### 900574###Co-Speaker###Clinical Pharmacist in Blood and Marrow Transplant/Cellular Immunotherapy###Moffitt Cancer Center###Co-Speaker: – Moffitt Cancer Center
### she/her/hers
5:00 PM – 7:30 PM
E-Poster Reception - Completed & Late Breaking Research + Trainee Top Ten
5:00 PM – 7:30 PM
E-Poster Reception - Completed & Late Breaking Research + Trainee Top TenLocation: Exhibit HallResearch
6:30 PM – 7:30 PM
Non-CE Symposia: LUNSUMIO (mosunetuzumab-axgb): A Novel, First-in-class, T-cell Engaging Bispecific Antibody in 3L+ Follicular Lymphoma
6:30 PM – 7:30 PM
Non-CE Symposia: LUNSUMIO (mosunetuzumab-axgb): A Novel, First-in-class, T-cell Engaging Bispecific Antibody in 3L+ Follicular LymphomaLocation: 158
Ramiro Garza III ### 1896106###*Speaker#########*Speaker:
### 6:30 PM – 7:30 PM
Non-CE Symposia: Treatment and management of myelofibrosis
6:30 PM – 7:30 PM
Non-CE Symposia: Treatment and management of myelofibrosis
Location: 159
6:30 PM – 8:00 PM
IRC Reception (Invite Only)
6:30 PM – 8:00 PM
IRC Reception (Invite Only)
Location: Hyatt (Second Floor)
- Friday, March 31, 2023
6:00 AM – 7:00 AM
Yoga & Meditation
6:00 AM – 7:00 AM
Yoga & Meditation
Location: 150-151
7:00 AM – 8:00 AM
CE Symposia: Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effective Care With Targeted Therapy
7:00 AM – 8:00 AM
CE Symposia: Crafting the New Treatment Mix in CLL: Pharmacist Insights on Delivering Effective Care With Targeted Therapy Location: 159*Speaker: – The James Cancer Hospital Columbus, Ohio
*Speaker: – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center
*Speaker: – Memorial Sloan Kettering Cancer Center
Emily Dotson, PharmD, BCOP – The James Cancer Hospital Columbus, Ohio ### 957908###*Speaker######The James Cancer Hospital Columbus, Ohio###*Speaker: – The James Cancer Hospital Columbus, Ohio
### @@@ Peter Campbell, PharmD, MBA, BCOP – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center ### 1589099###*Speaker######NewYork-Presbyterian Hospital, Columbia University Irving Medical Center###*Speaker: – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center
### @@@ Sarah E. Stump, PharmD, BCPS, BCOP – Memorial Sloan Kettering Cancer Center ### 1195640###*Speaker###Clinical Pharmacy Specialist - Leukemia###Memorial Sloan Kettering Cancer Center###*Speaker: – Memorial Sloan Kettering Cancer Center
### 7:00 AM – 8:00 AM
CE Symposia: The Pharmacist View: Key Considerations for Optimal Myelofibrosis
7:00 AM – 8:00 AM
CE Symposia: The Pharmacist View: Key Considerations for Optimal Myelofibrosis Management Location: 157*Speaker: – University of Colorado School of Medicine Anschutz Medical Campus
*Speaker: – University of Michigan Rogel Cancer Center
*Speaker: – The University of Texas MD Anderson Cancer Center
Brandon McMahon, MD – University of Colorado School of Medicine Anschutz Medical Campus ### 1917223###*Speaker###Professor of Medicine###University of Colorado School of Medicine Anschutz Medical Campus###*Speaker: – University of Colorado School of Medicine Anschutz Medical Campus
### @@@ Victoria R. Nachar, PharmD, BCOP – University of Michigan Rogel Cancer Center ### 1094223###*Speaker###Clinical Pharmacist###University of Michigan Rogel Cancer Center###*Speaker: – University of Michigan Rogel Cancer Center
### @@@ Shilpa Paul, PharmD, BCOP – The University of Texas MD Anderson Cancer Center ### 894800###*Speaker###Clinical Pharmacy Specialist- Leukemia###The University of Texas MD Anderson Cancer Center###*Speaker: – The University of Texas MD Anderson Cancer Center
### 7:00 AM – 8:00 AM
CE Symposia: Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient Care
7:00 AM – 8:00 AM
CE Symposia: Translating Progress in BCMA-Directed Therapy for Multiple Myeloma into Advances in Patient CareLocation: 158*Speaker: – Emory Healthcare
*Speaker: – University of Kansas Cancer Center
*Speaker:
Kathryn Maples, PharmD, BCOP – Emory Healthcare ### 1459174###*Speaker###Clinical Pharmacy Specialist, Multiple Myeloma###Emory Healthcare###*Speaker: – Emory Healthcare
### @@@ Zahra Mahmoudjafari, PharmD, MBA, BCOP (she/her/hers) – University of Kansas Cancer Center ### 958456###*Speaker###Clinical Pharmacy Manager-Hem/BMT/CAR-T###University of Kansas Cancer Center###*Speaker: – University of Kansas Cancer Center
### she/her/hers @@@ Tyler Sandahl, PharmD, BCOP, RPh ### 1896149###*Speaker#########*Speaker:
### 7:00 AM – 8:00 AM
Exhibits and IRC Encore Posters
7:00 AM – 8:00 AM
Exhibits and IRC Encore Posters
Location: Exhibit Hall
8:00 AM – 9:00 AM
Significant Updates in Hematology
8:00 AM – 9:00 AM
301 - Significant Updates in HematologyLocation: 160-163Speaker: – Norton Cancer Institute
Rebecca Champion, PharmD, BCOP (she/her/hers) – Norton Cancer Institute ### 1792809###Speaker###Clinical Pharmacy Manager###Norton Cancer Institute###Speaker: – Norton Cancer Institute
### she/her/hers
8:00 AM – 9:00 AM
Turning Up the Heat on Melanoma: Exploring Novel Immunotherapies in the Classic “Hot” Tumor
8:00 AM – 9:00 AM
BC5 - Turning Up the Heat on Melanoma: Exploring Novel Immunotherapies in the Classic “Hot” TumorLocation: BallroomSpeaker: – Beth Israel Deaconess Medical Center
BCOP
Julia Stevens, PharmD, BCOP – Beth Israel Deaconess Medical Center ### 947694###Speaker###Clinical Pharmacy Specialist - Ambulatory Oncology###Beth Israel Deaconess Medical Center###Speaker: – Beth Israel Deaconess Medical Center
###
9:15 AM – 10:15 AM
Clinical Utility of Germline Pharmacogenetic Testing in Patients with Cancer
9:15 AM – 10:15 AM
303 - Clinical Utility of Germline Pharmacogenetic Testing in Patients with CancerLocation: BallroomSpeaker: – Levine Cancer Institute, Atrium Health
Jai N. Patel, PharmD, BCOP, CPP (he/him/his) – Levine Cancer Institute, Atrium Health ### 1171470###Speaker###Chair, Department of Cancer Pharmacology & Pharmacogenomics###Levine Cancer Institute, Atrium Health###Speaker: – Levine Cancer Institute, Atrium Health
### he/him/his
9:15 AM – 10:15 AM
Gaining Traction: Novel Targets and Treatment Strategies in Biliary Tract Cancer
9:15 AM – 10:15 AM
302 - Gaining Traction: Novel Targets and Treatment Strategies in Biliary Tract CancerLocation: 160-163
Mark L. Zangardi, PharmD, MS, BCOP (he/him/his) – OhioHealth ### 1774207###Speaker###Pharmacy Coordinator, Oncology Precision Medicine###OhioHealth###Speaker: – OhioHealth
### he/him/his
9:15 AM – 10:15 AM
Grab that Iron! Practical Considerations of Iron Chelation
9:15 AM – 10:15 AM
304 - Grab that Iron! Practical Considerations of Iron ChelationLocation: 164-167
Catherine Martin, PharmD, BCOP (she/her/hers) – Mayo Clinic ### 1808423###Speaker###Clinical Pharmacist###Mayo Clinic###Speaker: – Mayo Clinic
### she/her/hers
9:15 AM – 10:15 AM
Microsatellite Instability in Early-Stage Colorectal Cancer: Are the Data Strong or Still Shaky?
9:15 AM – 10:15 AM
302 - Microsatellite Instability in Early-Stage Colorectal Cancer: Are the Data Strong or Still Shaky?Location: 160-163Speaker: – The Ohio State University James Comprehensive Cancer Center
Matthew Arango, PharmD, BCOP – The Ohio State University James Comprehensive Cancer Center ### 1177730###Speaker###Specialty Practice Pharmacist###The Ohio State University James Comprehensive Cancer Center###Speaker: – The Ohio State University James Comprehensive Cancer Center
###
9:15 AM – 10:15 AM
The Chicken or the Egg? Adverse Effect Management for Novel Drug Combinations in the Era of Oncology Precision Medicine
9:15 AM – 10:15 AM
303 - The Chicken or the Egg? Adverse Effect Management for Novel Drug Combinations in the Era of Oncology Precision MedicineLocation: BallroomSpeaker: – Froedtert & the Medical College of Wisconsin
Carolyn Oxencis, PharmD, BCOP (she/her/hers) – Froedtert & the Medical College of Wisconsin ### 1774211###Speaker###Pharmacogenomics and Oncology Precision Medicine Pharmacist###Froedtert & the Medical College of Wisconsin###Speaker: – Froedtert & the Medical College of Wisconsin
### she/her/hers
9:15 AM – 10:15 AM
What’s Cooler Than Being Cool: Updates in Cold Agglutinin Disease
9:15 AM – 10:15 AM
304 - What’s Cooler Than Being Cool: Updates in Cold Agglutinin Disease Location: 164-167Speaker: – Michigan Medicine
Madeleine A. Ochs, PharmD, BCOP – Michigan Medicine ### 1252118###Speaker###Clinical Pharmacist Specialist, Inpatient Hematology###Michigan Medicine###Speaker: – Michigan Medicine
###
10:15 AM – 10:45 AM
Member Awards + Business Meeting
10:15 AM – 10:45 AM
Member Awards + Business Meeting
Location: Ballroom
11:00 AM – 12:00 PM
Research Grant Award: Remote patient-reported quality of life outcomes in patients on oral anti-cancer therapy
11:00 AM – 12:00 PM
305 - Research Grant Award: Remote patient-reported quality of life outcomes in patients on oral anti-cancer therapyLocation: BallroomSpeaker: – Oregon Health and Science University
Research
Alison M. Palumbo, PharmD, MPH, BCOP (she/her/hers) – Oregon Health and Science University ### 1810471###Speaker###Clinical Oncology Pharmacist###Oregon Health and Science University###Speaker: – Oregon Health and Science University
### she/her/hers
12:00 PM – 1:00 PM
Non-CE Symposia: Discussing Anticancer Therapy Along With Patient Monitoring and Management of Adverse Events
12:00 PM – 1:00 PM
Non-CE Symposia: Discussing Anticancer Therapy Along With Patient Monitoring and Management of Adverse EventsLocation: 158
Mark Wagner, PharmD ### 1917234###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
Non-CE Symposia: Explore data for an FDA-approved treatment option in HR+, HER2- breast cancer in certain adjuvant or metastatic settings.
PP-AL-US-2989 © Lilly USA, LLC 2021. All rights reserved.
12:00 PM – 1:00 PM
Non-CE Symposia: Explore data for an FDA-approved treatment option in HR+, HER2- breast cancer in certain adjuvant or metastatic settings.PP-AL-US-2989 © Lilly USA, LLC 2021. All rights reserved.Location: 157
Katheryn Moreira, MD, MBA ### 1939658###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
Non-CE Symposia: In Practice: Combination Treatment Options with IO in mNSCLC and uHCC
12:00 PM – 1:00 PM
Non-CE Symposia: In Practice: Combination Treatment Options with IO in mNSCLC and uHCC
Christopher Walczak, PharmD ### 1589100###*Speaker#########*Speaker:
### 12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
12:00 PM – 1:00 PM
What's the Scoop with the Board of Directors?
Location: Ballroom Lobby
12:00 PM – 2:00 PM
Poster Session - Trainee Research (Even #)
12:00 PM – 2:00 PM
Poster Session - Trainee Research (Even #)Location: Exhibit HallResearch
1:00 PM – 2:00 PM
2023 Patient Advocacy Session
1:00 PM – 2:00 PM
Patient Advocacy: Empowering Our Patients to Become Self-Advocates: Improving Patient Care Together (Non-CE)Location: 160-163*Speaker: – West Virginia University Medicine
Advocacy
Jordan Hill, PharmD, BCOP – West Virginia University Medicine ### 1772979###*Speaker###Clinical Pharmacy Specialist - Oncology###West Virginia University Medicine###*Speaker: – West Virginia University Medicine
###
2:30 PM – 3:00 PM
Incoming President's Remarks + Board Awards
2:30 PM – 3:00 PM
Incoming President's Remarks + Board Awards Location: BallroomPresenter: – Atrium Health Wake Forest Baptist (WFB)
LeAnne Kennedy, PharmD, BCOP, CPP, FHOPA – Atrium Health Wake Forest Baptist (WFB) ### 1311883###Presenter###Clinical Specialist - Stem Cell Transplant and Cellular Therapy###Atrium Health Wake Forest Baptist (WFB)###Presenter: – Atrium Health Wake Forest Baptist (WFB)
### 3:15 PM – 4:30 PM
Giving orphan drugs a home: A case-based approach to the management of rare leukemic entities
3:15 PM – 4:30 PM
BC6 - Giving orphan drugs a home: A case-based approach to the management of rare leukemic entitiesLocation: BallroomCo-Speaker: – Michigan Medicine, University of Michigan
Co-Speaker: – University of Michigan
BCOP
Lydia Benitez, PharmD, BCOP – Michigan Medicine, University of Michigan ### 1540118###Co-Speaker###Clinical Assistant Professor of Pharmacy###Michigan Medicine, University of Michigan###Co-Speaker: – Michigan Medicine, University of Michigan
### @@@ Bernard L. Marini, PharmD, BCOP (he/him/his) – University of Michigan ### 1254284###Co-Speaker###Clinical Pharmacist Specialist - Hematology###University of Michigan###Co-Speaker: – University of Michigan
### he/him/his
3:15 PM – 4:30 PM
Incorporating Social Determinants of Health and Sexual Orientation and Gender Identity Data Collection into Clinical Workflows
3:15 PM – 4:30 PM
306 - Incorporating Sexual Orientation and Gender Identity Data into Oncology Patient CareLocation: 160-163Co-Speaker: – Sutter Sacramento Medical Center
Co-Speaker: – Massachusetts College of Pharmacy & Health Sciences
Co-Speaker: – Eastern Idaho Regional Medical Center
Maya Leiva, PharmD, BCOP (she/her/hers) – Sutter Sacramento Medical Center ### 1774216###Co-Speaker###Senior Clinical Oncology Pharmacist###Sutter Sacramento Medical Center###Co-Speaker: – Sutter Sacramento Medical Center
### she/her/hers @@@ Christy S. Harris, PharmD, BCOP, FHOPA (she/her/hers) – Massachusetts College of Pharmacy & Health Sciences ### 1410926###Co-Speaker###Associate Professor of Pharmacy Practice###Massachusetts College of Pharmacy & Health Sciences###Co-Speaker: – Massachusetts College of Pharmacy & Health Sciences
### she/her/hers @@@ Leslie Harris, PharmD, BCOP (she/her/hers) – Eastern Idaho Regional Medical Center ### 1805701###Co-Speaker###Advanced Clinical Pharmacist Oncology ###Eastern Idaho Regional Medical Center ###Co-Speaker: – Eastern Idaho Regional Medical Center
### she/her/hers
4:45 PM – 5:45 PM
Beyond the Title: The Accidental or New Leader
4:45 PM – 5:45 PM
308 - Beyond the Title: The Accidental or New Leader Location: 160-163Speaker: – The Ohio State University Comprehensive Cancer Center
Practice Management
Julie Kennerly-Shah, PharmD, MS, MHA, BCPS – The Ohio State University Comprehensive Cancer Center ### 1774215###Speaker###Associate Director, Pharmacy###The Ohio State University Comprehensive Cancer Center###Speaker: – The Ohio State University Comprehensive Cancer Center
###
4:45 PM – 5:45 PM
Triplet Therapy for Metastatic Prostate Cancer
4:45 PM – 5:45 PM
307 - Three's a Crowd: Triplet Therapy for Metastatic Prostate CancerLocation: BallroomSpeaker: – University of Rochester Medical Center
Bryan Fitzgerald, PharmD, BCOP (he/him/his) – University of Rochester Medical Center ### 1774218###Speaker###Clinical Pharmacy Specialist###University of Rochester Medical Center###Speaker: – University of Rochester Medical Center
### he/him/his
6:00 PM – 7:00 PM
CE Symposia: Optimizing Safe Use of Antibody-Drug Conjugates in Solid Tumors Through Pharmacist Interventions
6:00 PM – 7:00 PM
CE Symposia: Optimizing Safe Use of Antibody-Drug Conjugates in Solid Tumors Through Pharmacist Interventions Location: 159*Speaker:
*Speaker: – University of Michigan Medicine
*Speaker: – University of Virginia Health System
Laura Bobolts, PharmD, BCOP ### 1896150###*Speaker#########*Speaker:
### @@@ Allison Schepers, PharmD, BCOP – University of Michigan Medicine ### 1094222###*Speaker###Clinical Pharmacist Specialist, Inpatient Medical Oncology###University of Michigan Medicine###*Speaker: – University of Michigan Medicine
### @@@ Andrew Whitman, PharmD – University of Virginia Health System ### 894808###*Speaker###Lead Clinical Pharmacist - Oncology/Hematology###University of Virginia Health System###*Speaker: – University of Virginia Health System
### 6:00 PM – 7:00 PM
CE Symposia: Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based Regimens
6:00 PM – 7:00 PM
CE Symposia: Ushering in a New Era of Targeted Therapies in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Focus on New and Emerging Antibody-Based RegimensLocation: 158*Speaker: – Duquesne University School of Pharmacy
*Speaker: – Emory Healthcare - Winship Cancer Institute
*Speaker: – University of Michigan Rogel Cancer Center
Karen Fancher, PharmD, BCOP – Duquesne University School of Pharmacy ### 894757###*Speaker###Assistant Professor of Pharmacy Practice###Duquesne University School of Pharmacy###*Speaker: – Duquesne University School of Pharmacy
### @@@ Arpita Gandhi, PharmD, BCOP – Emory Healthcare - Winship Cancer Institute ### 1774202###*Speaker###Hematology/Oncology Clinical Pharmacy Specialist###Emory Healthcare - Winship Cancer Institute###*Speaker: – Emory Healthcare - Winship Cancer Institute
### @@@ Victoria R. Nachar, PharmD, BCOP – University of Michigan Rogel Cancer Center ### 1094223###*Speaker###Clinical Pharmacist###University of Michigan Rogel Cancer Center###*Speaker: – University of Michigan Rogel Cancer Center
### 7:00 PM – 9:00 PM
Closing Reception
7:00 PM – 9:00 PM
Closing Reception
Location: Ballroom Terrace
- Saturday, April 1, 2023
7:00 AM – 8:00 AM
CE Symposia: Continuing the Conversation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Addressing Operational Challenges and Integrating New and Emerging Antibody-Based Regimens
7:00 AM – 8:00 AM
CE Symposia: Continuing the Conversation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Addressing Operational Challenges and Integrating New and Emerging Antibody-Based RegimensLocation: 159*Speaker: – Duquesne University School of Pharmacy
*Speaker: – Emory Healthcare - Winship Cancer Institute
*Speaker: – University of Michigan Rogel Cancer Center
Karen Fancher, PharmD, BCOP – Duquesne University School of Pharmacy ### 894757###*Speaker###Assistant Professor of Pharmacy Practice###Duquesne University School of Pharmacy###*Speaker: – Duquesne University School of Pharmacy
### @@@ Arpita Gandhi, PharmD, BCOP – Emory Healthcare - Winship Cancer Institute ### 1774202###*Speaker###Hematology/Oncology Clinical Pharmacy Specialist###Emory Healthcare - Winship Cancer Institute###*Speaker: – Emory Healthcare - Winship Cancer Institute
### @@@ Victoria R. Nachar, PharmD, BCOP – University of Michigan Rogel Cancer Center ### 1094223###*Speaker###Clinical Pharmacist###University of Michigan Rogel Cancer Center###*Speaker: – University of Michigan Rogel Cancer Center
### 7:00 AM – 8:00 AM
CE Symposia: Optimizing Outcomes for Older Patients With Acute Myeloid Leukemia: A Focus on Alternative Induction Regimens and Maintenance Therapy
7:00 AM – 8:00 AM
CE Symposia: Optimizing Outcomes for Older Patients With Acute Myeloid Leukemia: A Focus on Alternative Induction Regimens and Maintenance Therapy Location: 158*Speaker: – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center
*Speaker: – St Luke's Cancer Institute
*Speaker: – University of Texas MD Anderson Cancer Center
Peter Campbell, PharmD, MBA, BCOP – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center ### 1589099###*Speaker######NewYork-Presbyterian Hospital, Columbia University Irving Medical Center###*Speaker: – NewYork-Presbyterian Hospital, Columbia University Irving Medical Center
### @@@ Robert S. Mancini, PharmD, BCOP, FHOPA – St Luke's Cancer Institute ### 1486422###*Speaker###BMT Pharmacy Program Coordinator and PGY2 Residency Director###St Luke's Cancer Institute###*Speaker: – St Luke's Cancer Institute
### @@@ Kayleigh R. Marx, PharmD, BCOP – University of Texas MD Anderson Cancer Center ### 1247573###*Speaker###Clinical Pharmacy Specialist, Leukemia###University of Texas MD Anderson Cancer Center###*Speaker: – University of Texas MD Anderson Cancer Center
### 8:00 AM – 9:00 AM
How Do I Compare? Results of the Oncology Practice Landscape Survey from the Practice Outcomes and Professional Benchmarking Committee
8:00 AM – 9:00 AM
402 - How Do I Compare? Results of the Oncology Practice Landscape Survey from the Practice Outcomes and Professional Benchmarking CommitteeLocation: 160-163Co-Speaker: – University of California, Irvine
Co-Speaker: – Memorial Sloan Kettering Cancer Center
Co-Speaker: – Roswell Park Comprehensive Cancer Center
Practice Management
Shawn P. Griffin, PharmD, BCOP (he/him/his) – University of California, Irvine ### 1772980###Co-Speaker###Assistant Clinical Professor###University of California, Irvine###Co-Speaker: – University of California, Irvine
### he/him/his @@@ Stephen Harnicar, PharmD, BCOP (he/him/his) – Memorial Sloan Kettering Cancer Center ### 1806654###Co-Speaker###Manager, Clinical Pharmacy Practice & Research###Memorial Sloan Kettering Cancer Center###Co-Speaker: – Memorial Sloan Kettering Cancer Center
### he/him/his @@@ Grazyna Riebandt, PharmD, BCOP (she/her/hers) – Roswell Park Comprehensive Cancer Center ### 1806655###Co-Speaker###Clinical Pharmacy Services Director###Roswell Park Comprehensive Cancer Center###Co-Speaker: – Roswell Park Comprehensive Cancer Center
### she/her/hers
8:00 AM – 9:00 AM
Postmarketing Safety in Oncology: An Overview of Pharmacovigilance at the FDA
8:00 AM – 9:00 AM
401 - Postmarketing Safety in Oncology: An Overview of Pharmacovigilance at the FDALocation: BallroomSpeaker: – U.S. Food and Drug Administration
Practice Management
Lauren McBride, PharmD, BCOP, FHOPA (she/her/hers) – U.S. Food and Drug Administration ### 1486421###Speaker###Oncology Safety Evaluator###U.S. Food and Drug Administration###Speaker: – U.S. Food and Drug Administration
### she/her/hers
9:00 AM – 10:00 AM
Blast Off! A Review of Monoclonal Antibodies in Neuroblastoma Treatment (Pediatric Pearls Part 4)
9:00 AM – 10:00 AM
404 - Blast Off! A Review of Monoclonal Antibodies in Neuroblastoma Treatment (Pediatric Pearls Part 4)Location: 160-163Speaker: – Dartmouth Health
Pediatrics
Caitlin R. Harper, PharmD (she/her/hers) – Dartmouth Health ### 1810347###Speaker###Hematology/Oncology Clinical Pharmacist###Dartmouth Health###Speaker: – Dartmouth Health
### she/her/hers
9:00 AM – 10:00 AM
High Impact Pharmacogenomics in Pediatrics (Pediatric Pearls Part 3)
9:00 AM – 10:00 AM
404 - High Impact Pharmacogenomics in Pediatrics (Pediatric Pearls Part 3)Location: 160-163Pediatrics
Cathryn Jennissen, PharmD, BCOP – OneOme ### 1810346###Speaker###Senior Clinical Pharmacist ###OneOme###Speaker: – OneOme
###
9:00 AM – 10:00 AM
Investigational Drug Updates: Intratumoral Injections Bring Cancer Treatment Local
9:00 AM – 10:00 AM
405 - Investigational Drug Updates: Intratumoral Injections Bring Cancer Treatment Local Location: 164-167Speaker: – The Ohio State University Wexner Medical Center and James Cancer Hospital
Hallie Barr, PharmD, MBA, BCOP (she/her/hers) – The Ohio State University Wexner Medical Center and James Cancer Hospital ### 1390143###Speaker###Pharmacy Manager, Investigational Drug Service###The Ohio State University Wexner Medical Center and James Cancer Hospital###Speaker: – The Ohio State University Wexner Medical Center and James Cancer Hospital
### she/her/hers
9:00 AM – 10:00 AM
Position Justifications: Justifying the Return on Investment
9:00 AM – 10:00 AM
403 - Position Justifications: Justifying the Return on InvestmentLocation: BallroomSpeaker: – University of Kansas Cancer Center
Practice Management
Zahra Mahmoudjafari, PharmD, MBA, BCOP (she/her/hers) – University of Kansas Cancer Center ### 958456###Speaker###Clinical Pharmacy Manager-Hem/BMT/CAR-T###University of Kansas Cancer Center###Speaker: – University of Kansas Cancer Center
### she/her/hers
9:00 AM – 10:00 AM
SOS…Defibrotide Prophylaxis for the Prevention of Sinusoidal Obstruction Syndrome in pediatric stem cell (Pediatric Pearls Part 1)
9:00 AM – 10:00 AM
404 - SOS…Defibrotide Prophylaxis for the Prevention of Sinusoidal Obstruction Syndrome in pediatric stem cell (Pediatric Pearls Part 1) Location: 160-163Speaker: – Childrens National Hospital
Pediatrics
Radha Rohatgi, Pharm.D, BCOP (she/her/hers) – Childrens National Hospital ### 1810348###Speaker###BMT Clinical Pharmacy Specialist###Childrens National Hospital###Speaker: – Childrens National Hospital
### she/her/hers
9:00 AM – 10:00 AM
Spare a Thought for Asparaginase: Updates on Asparaginase (Pediatric Pearls Part 2)
9:00 AM – 10:00 AM
404 - Spare a Thought for Asparaginase: Updates on Asparaginase (Pediatric Pearls Part 2) Location: 160-163Speaker: – Children's Hospital Colorado
Pediatrics
Zanette Kanani Bradley, PharmD, BCOP (she/her/hers) – Children's Hospital Colorado ### 1810345###Speaker###Pediatric Ambulatory Oncology Clinical Pharmacy Specialist###Children's Hospital Colorado###Speaker: – Children's Hospital Colorado
### she/her/hers
10:15 AM – 11:15 AM
Updates in Amyloidosis
10:15 AM – 11:15 AM
406 - Updates in AmyloidosisLocation: 160-163Speaker: – Lymphoma Program and Lymphoma Translational Research, Department of Pharmacy, Abramson Cancer Center at the Hospital of the University of Pennsylvania
Mitchell E. Hughes, Pharm.D., BCOP (he/him/his) – Lymphoma Program and Lymphoma Translational Research, Department of Pharmacy, Abramson Cancer Center at the Hospital of the University of Pennsylvania ### 1774217###Speaker###Clinical Pharmacist Specialist, Hematology/Oncology/Cellular Therapy###Lymphoma Program and Lymphoma Translational Research, Department of Pharmacy, Abramson Cancer Center at the Hospital of the University of Pennsylvania###Speaker: – Lymphoma Program and Lymphoma Translational Research, Department of Pharmacy, Abramson Cancer Center at the Hospital of the University of Pennsylvania
### he/him/his
10:15 AM – 11:30 AM
What's New Down Under; Updates in Gynecologic Malignancy
10:15 AM – 11:30 AM
BC7 - What's New Down Under? Updates in Gynecologic MalignancyLocation: BallroomSpeaker: – Stephenson Cancer Center at OU Health
Co-Speaker: – Medical University of South Carolina
BCOP
Sarah K. Hayward, PharmD, BCOP – Stephenson Cancer Center at OU Health ### 1774203###Speaker###Clinical Pharmacy Specialist, Gynecologic Oncology###Stephenson Cancer Center at OU Health###Speaker: – Stephenson Cancer Center at OU Health
### @@@ Jennifer MacDonald, PharmD, BCOP – Medical University of South Carolina ### 1774204###Co-Speaker###Clinical Pharmacy Specialist- Gynecologic Oncology###Medical University of South Carolina###Co-Speaker: – Medical University of South Carolina
###
12:00 PM – 12:45 PM
Non-CE Symposia: Expanded Horizons: A Post-endocrine Option for Patients with HR+/HER2- mBC
12:00 PM – 12:45 PM
Non-CE Symposia: Expanded Horizons: A Post-endocrine Option for Patients with HR+/HER2- mBC Location: 159
Anne O'Dea, MD ### 1896158###*Speaker#########*Speaker:
### 12:00 PM – 12:45 PM
Non-CE Symposia: Time TBD (AbbVie)
12:00 PM – 12:45 PM
Non-CE Symposia: Pivotal Phase 3 Data in Newly Diagnosed AMLLocation: 158
Rami Komrokji, MD ### 957893###*Speaker#########*Speaker:
###
